Related content

Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS)

By Rutkowska Aleksandra   Rachoń Dominik  

Gynecological Endocrinology, Vol. 30, Iss. 4, 2014-04 ,pp. : 260-265

Informa Healthcare

Access to resources Recommend Favorite

Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response

By Palomba Stefano   Falbo Angela   Russo Tiziana   Orio Francesco   Tolino Achille   Zullo Fulvio  

Human Reproduction, Vol. 25, Iss. 4, 2010-04 ,pp. : 1005-1013

Oxford University Press

Access to resources Recommend Favorite

Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study

By Hanjalic-Beck Aida   Gabriel Boris   Schaefer Wolfgang   Zahradnik Hans-Peter   Schories Marcus   Tempfer Clemens   Keck Christoph   Denschlag Dominik  

Gynecological Endocrinology, Vol. 26, Iss. 9, 2010-09 ,pp. : 690-697

Informa Healthcare

Access to resources Recommend Favorite

The relationship of the Fas 670 A/G gene polymorphism with cardiovascular risk factors in polycystic ovary syndrome (PCOS) patients

By Cetinkalp Sevki   Erdogan Mehmet   Karadeniz Muammer   Berdeli Afig   Tamsel Sadik   Ozgen Ahmet Gokhan   Saygili Fusun   Yilmaz Candeger  

Gynecological Endocrinology, Vol. 26, Iss. 3, 2010-03 ,pp. : 167-172

Informa Healthcare

Access to resources Recommend Favorite

Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)

By Hossain Noreen   Stepanova Maria   Afendy Arian   Nader Fatema   Younossi Youssef   Rafiq Nila   Goodman Zachary   Younossi Zobair M.  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 4, 2011-04 ,pp. : 479-484

Informa Healthcare

Access to resources Recommend Favorite